CA
TSVT

CHI Advisors’s 2seventy bio TSVT Stock Holding History

CHI Advisors’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$3.93M Buy
1,002,007
+150,000
+18% +$984K 1.56% 16
2023
Q2 		$8.62M Sell
852,007
-2,993
-0.4% -$31.7K 2.62% 10
2023
Q1 		$8.72M Buy
855,000
+521,748
+157% +$5.97M 2.32% 9
2022
Q4 		$3.12M Sell
333,252
-196,971
-37% -$2.78M 0.83% 14
2022
Q3 		$7.71M Sell
530,223
-289,449
-35% -$4.3M 2.07% 9
2022
Q2 		$10.8M Hold
819,672
– – 4.13% 7
2022
Q1 		$14M Buy
+819,672
New +$13.9M 5.95% 6

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

CHI Advisors's TSVT Position: Q3 2023 in Review

CHI Advisors increased its 2seventy bio (TSVT) stake by 18% in Q3 2023, buying an estimated $984K and bringing the position to 1,002,007 shares worth $3.93M. The position accounts for 1.56% of the portfolio, ranked #16.

CHI Advisors first reported a position in TSVT in Q1 2022 and has held it in 7 quarters since. The position peaked at $14M in Q1 2022. 146 funds tracked by Wall St. Rank hold TSVT as of Q3 2023.

  • CHI Advisors held 1,002,007 shares of 2seventy bio worth $3.93M as of Q3 2023.
  • CHI Advisors bought 150,000 2seventy bio shares in Q3 2023, an estimated $984K.
  • 2seventy bio made up 1.56% of CHI Advisors's portfolio in Q3 2023, its #16 holding.
  • CHI Advisors first reported a position in 2seventy bio in Q1 2022 and has held it in 7 quarters since.
  • CHI Advisors's 2seventy bio position peaked at $14M in Q1 2022.
  • 146 funds tracked by Wall St. Rank held 2seventy bio as of Q3 2023.

Based on CHI Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.